NDC Package 84612-889-01 Wezlana

Ustekinumab-auub Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

84612-889-01

Package Description:

1 SYRINGE in 1 CARTON / 1 mL in 1 SYRINGE

Product Code:

84612-889

Proprietary Name:

Wezlana

Non-Proprietary Name:

Ustekinumab-auub

Substance Name:

Ustekinumab

Usage Information:

Ustekinumab is used to treat plaque psoriasis, a certain type of arthritis (psoriatic arthritis), or certain bowel conditions (Crohn's disease, ulcerative colitis). It works by blocking certain natural proteins in your body (interleukin-12 and interleukin-23) that cause inflammation (swelling) in these conditions. Ustekinumab does not cure these diseases, but helps to lessen symptoms of the disease. It can help to decrease the amount of plaques in plaque psoriasis, decrease the number of swollen/painful joints in psoriatic arthritis, and decrease symptoms such as abdominal pain/cramping and diarrhea in Crohn's disease and ulcerative colitis.

11-Digit NDC Billing Format:

84612088901

Billing Unit:

ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

NDC to RxNorm Crosswalk:

RxCUI: 2700669 - ustekinumab-auub 130 MG in 26 ML Injection
RxCUI: 2700669 - 26 ML ustekinumab-auub 5 MG/ML Injection
RxCUI: 2700669 - ustekinumab-auub 130 MG per 26 ML Injection
RxCUI: 2700669 - ustekinumab-auub 5 MG/ML per 26 ML Injection
RxCUI: 2700676 - WEZLANA 130 MG in 26 ML Injection

Product Type:

Human Prescription Drug

Labeler Name:

Optum Health Solutions (ireland) Limited

Dosage Form:

Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.

Administration Route(s):

Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.

Active Ingredient(s):

USTEKINUMAB 90 mg/mL

Pharmacologic Class(es):

Sample Package:

FDA Application Number:

BLA761285

Marketing Category:

BLA - A product marketed under an approved Biologic License Application.

Start Marketing Date:

01-01-2025

Listing Expiration Date:

12-31-2026

Exclude Flag:

Code Structure:

84612 - Optum Health Solutions (ireland) Limited
- 84612-889 - Wezlana
  - 84612-889-01 - 1 SYRINGE in 1 CARTON / 1 mL in 1 SYRINGE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 84612-889-01?

The NDC Packaged Code 84612-889-01 is assigned to a package of 1 syringe in 1 carton / 1 ml in 1 syringe of Wezlana, a human prescription drug labeled by Optum Health Solutions (ireland) Limited. The product's dosage form is injection, solution and is administered via subcutaneous form.

Is NDC 84612-889 included in the NDC Directory?

Yes, Wezlana with product code 84612-889 is active and included in the NDC Directory. The product was first marketed by Optum Health Solutions (ireland) Limited on January 01, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 84612-889-01?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 84612-889-01?

The 11-digit format is 84612088901. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	84612-889-01	5-4-2	84612-0889-01

Table of Contents